Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Purkinje cell pathology and loss in multiple sclerosis cerebellum.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world.
Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Neurofilaments as biomarkers in multiple sclerosis.
Heat shock protein 27 in multiple sclerosis relapses.
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
Can we safely target the WNT pathway?
The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Indicators for cognitive performance and subjective cognitive complaints in multiple sclerosis: a role for advanced MRI?
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the boston area community health (BACH) survey.
Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
Impact of Clear, Loud and Slow Speech on Scaled Intelligibility and Speech Severity in Parkinson's Disease and Multiple Sclerosis.
Substance Name: MEDI 551
Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
Daughters of mothers with multiple sclerosis: their experiences of play.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.

Pages